Multiple Chinese biotech companies with deposits at Silicon Valley Bank (SVB) said that the failure of the California-based bank will have a limited impact on their operations. US and Hong Kong dual-listed BeiGene said it held $175 million uninsured cash deposits at SVB, Tianjin-based Andon Health announced it had 5% of its cash locked up[…[…
阅读更多（Read More）
SVB fallout will have no major impact on operations, say Chinese biotech firms
作者gocpmall
3 月 28, 2023